Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Exscientia tees up an IPO for its AI drug discovery platform, likely not willing to settle for just $100M
4 years ago
Financing
AI
Covid-19 roundup: UK pulls out of billion-dollar vaccine supply deal as nation embraces mix-and-match booster ...
4 years ago
Coronavirus
FDA head Janet Woodcock raises patent-related concerns to PTO director
4 years ago
FDA+
Sanofi places new $1.9B bet even as its last sours; Sam Waksal's new biotech ideas; Cell therapy time for Roche; and ...
4 years ago
Weekly
Canada's Bausch to pay $300M in antitrust settlement; Cardiff releases data on mCRC trial
4 years ago
News Briefing
Boehringer Ingelheim taps a popular antibody discovery player for access to drug 'library of libraries'
4 years ago
Deals
Not just the approved indications: FDA to study DTC drug ads that include secondary endpoint data
4 years ago
FDA+
In a first, FDA warns a researcher for failing to submit data 3 years after trial completion
4 years ago
FDA+
IPO filings are back on the biotech menu as an ADHD drug developer submits its Nasdaq paperwork
4 years ago
Financing
Martin Shkreli to go toe-to-toe with new FTC chair over Daraprim price spikes
4 years ago
People
Covid-19 roundup: BioNTech prepares for vaccine launch in 5- to 11-year-olds; Sinovac weighs vaccine production site ...
4 years ago
Coronavirus
Biden calls on Congress to allow Medicare drug price negotiations
4 years ago
R&D
Pharma
A longevity researcher and wealthy backers launch fast grants to fund ‘crazy ideas’ in anti-aging research
4 years ago
Financing
After decade-plus of failures, AstraZeneca finally gets a win for storied immunotherapy (kind of)
4 years ago
R&D
Flagship keeps ex-FDA commish Stephen Hahn busy with another CMO gig; Daphne Koller makes key hire at insitro by ...
4 years ago
Peer Review
Apellis turns up mixed results in closely watched eye disease tests. Are the data strong enough for approval?
4 years ago
R&D
AstraZeneca amends license deal with Chinese biotech; Chinese protein-based vaccine gets manufacturing OK
4 years ago
Manufacturing
Biogen CEO Vounatsos laments 'confusion' and 'misinformation' leading to challenges with Aduhelm uptake
4 years ago
Pharma
Vector Labs decouples from Maravai, popping up shop with private capital, new CEO on board
4 years ago
Manufacturing
Recro takes on big brother role with opioid addiction drug maker, handling manufacturing duties and advising on FDA ...
4 years ago
Manufacturing
Thermo Fisher, as part of global expansion plans, outlines new single-use site in Nashville
4 years ago
Manufacturing
Covid-19 manufacturing roundup: Russia will produce Sputnik V in Peru — report; CEPI calls for established vaccine ...
4 years ago
Manufacturing
Recall report: Amino acid IV pulled after hair, other foreign substances found in batch
4 years ago
Manufacturing
Roche to buy up diagnostics partner TIB Molbiol; PAQ to partner with Insilico
4 years ago
News Briefing
First page
Previous page
651
652
653
654
655
656
657
Next page
Last page
